日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Assessing the value of orphan drugs using conventional cost-effectiveness analysis: Is it fit for purpose?

使用传统的成本效益分析来评估孤儿药的价值:它是否符合目的?

Postma, Maarten J; Noone, Declan; Rozenbaum, Mark H; Carter, John A; Botteman, Marc F; Fenwick, Elisabeth; Garrison, Louis P

Changes in Healthcare Resource Use and Costs in Commercially Insured Insomnia Patients Initiating Suvorexant

接受舒沃雷生治疗的商业保险失眠患者医疗资源使用和成本的变化

Kale, Hrishikesh P; Qureshi, Zaina P; Shah, Ruchit; Khandker, Rezaul; Botteman, Marc; Meng, Weilin; Benca, Ruth

CTNI-30. A SNAPSHOT OF “REAL WORLD” CURRENT NEURO-ONCOLOGY PRACTICE IN TEN UK CENTRES AND RATIONALE FOR THE TESSA JOWELL BRAIN MATRIX (TJBM) PLATFORM STUDY

CTNI-30. 英国十个中心“真实世界”当前神经肿瘤学实践的概览及Tessa Jowell脑矩阵(TJBM)平台研究的理论依据

Waldeck, A Reginald; Botteman, Marc F; White, Richard E; van Hout, Ben A; Teraishi, Ashley; Sanvito, Francesco; Cho, Nicholas; Raymond, Catalina; Lai, Albert; Nghiemphu, Phioanh; Salamon, Noriko; Cloughesy, Timothy; Ellingson, Benjamin; Wykes, Victoria; Apps, John; Savage, Joshua; Meade, Sara; Pohl, Ute; Sawlani, Vijay; Patel, Amit; Billingham, Lucinda; Thompson, Gerard; Waldman, Adam; Ansorge, Olaf; Watts, Colin

Impact of Non-Cardiac Clinicopathologic Characteristics on Survival in Transthyretin Amyloid Polyneuropathy

非心脏临床病理特征对转甲状腺素蛋白淀粉样变性多发性神经病患者生存率的影响

González-Duarte, Alejandra; Conceição, Isabel; Amass, Leslie; Botteman, Marc F; Carter, John A; Stewart, Michelle

Patient and caregiver benefit-risk preferences for nonmetastatic castration-resistant prostate cancer treatment

患者和照护者对非转移性去势抵抗性前列腺癌治疗的获益风险偏好

Srinivas, Sandy; Mohamed, Ateesha F; Appukkuttan, Sreevalsa; Botteman, Marc; Ng, Xinyi; Joshi, Namita; Tsai, Jui-Hua; Fang, Jarjieh; Waldeck, A Reginald; Simmons, Stacey J

Cost-effectiveness of a fixed combination of netupitant and palonosetron (NEPA) relative to aprepitant plus granisetron (APR + GRAN) for prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a trial-based analysis

奈妥匹坦联合帕洛诺司琼(NEPA)与阿瑞匹坦联合格拉司琼(APR + GRAN)预防化疗引起的恶心呕吐(CINV)的成本效益分析:一项基于试验的分析

Botteman, Marc; Nickel, Katharina; Corman, Shelby; Turini, Marco; Binder, Gary

Survival, costs, and health care resource use by line of therapy in US Medicare patients with newly diagnosed glioblastoma: a retrospective observational study

美国医疗保险(Medicare)新诊断胶质母细胞瘤患者的生存率、治疗费用和医疗资源利用情况按治疗方案分类:一项回顾性观察研究

Aly, Abdalla; Singh, Prianka; Korytowsky, Beata; Ling, You-Li; Kale, Hrishikesh P; Dastani, Homa B; Botteman, Marc F; Norden, Andrew D

Physician preferences for non-metastatic castration-resistant prostate cancer treatment

医生对非转移性去势抵抗性前列腺癌治疗的偏好

Srinivas, Sandy; Mohamed, Ateesha F; Appukkuttan, Sreevalsa; Botteman, Marc; Ng, Xinyi; Joshi, Namita; Horodniceanu, Erica; Waldeck, A Reginald; Simmons, Stacey J

Landscape of Health-Related Quality of Life in Patients With Early-Stage Pancreatic Cancer Receiving Adjuvant or Neoadjuvant Chemotherapy: A Systematic Literature Review

接受辅助或新辅助化疗的早期胰腺癌患者健康相关生活质量概况:系统性文献综述

Macarulla, Teresa; Hendifar, Andrew E; Li, Chung-Pin; Reni, Michele; Riess, Hanno; Tempero, Margaret A; Dueck, Amylou C; Botteman, Marc F; Deshpande, Chinmay G; Lucas, Eleanor J; Oh, Do-Youn

Epidemiological and clinical characteristics of symptomatic hereditary transthyretin amyloid polyneuropathy: a global case series

症状性遗传性转甲状腺素蛋白淀粉样变性多发性神经病的流行病学和临床特征:全球病例系列研究

Waddington-Cruz, Márcia; Schmidt, Hartmut; Botteman, Marc F; Carter, John A; Stewart, Michelle; Hopps, Markay; Fallet, Shari; Amass, Leslie